Related Experiment Videos
Antigenic analysis of isolated polypeptides from Visna virus
Infection and Immunity
|June 1, 1976
Summary
Researchers investigated Visna virus polypeptides using guanidine hydrochloride (GuHCl) separation. They identified a 25,000 molecular weight polypeptide responsible for antigenic activity in GuHCl 1 and GuHCl 9 fractions.
Area of Science:
- Virology
- Immunology
- Protein Chemistry
Background:
- Visna virus, a lentivirus, causes progressive neurological disease in sheep.
- Understanding the antigenic properties of Visna virus is crucial for vaccine development and diagnostics.
- Previous studies have characterized some Visna virus proteins, but their specific antigenic contributions require further elucidation.
Purpose of the Study:
- To identify and characterize the specific Visna virus polypeptides responsible for antigenic activity.
- To determine the molecular weight and composition of immunologically active Visna virus fractions.
Main Methods:
- Separation of Visna virus polypeptides using gel filtration in 6 M guanidine hydrochloride (GuHCl).
- Antigenic activity assessment via immunodiffusion, passive hemagglutination, and complement fixation tests using rabbit antisera specific for Visna virus.
- Molecular weight determination of polypeptides using polyacrylamide gel electrophoresis (PAGE) with sodium lauryl sulfate (SLS).
Main Results:
- Two polypeptide peaks, GuHCl 1 and GuHCl 9, demonstrated antigenic activity.
- GuHCl 1 showed weaker reactivity compared to GuHCl 9 and whole virus across all tested immunological assays.
- GuHCl 9 contained a single polypeptide of 25,000 molecular weight, while GuHCl 1 contained an aggregate including a major 25,000 molecular weight polypeptide.
Conclusions:
- The antigenic activity of Visna virus fractions GuHCl 1 and GuHCl 9 is associated with a single polypeptide of 25,000 molecular weight.
- This 25,000 molecular weight polypeptide is a key antigenic determinant of Visna virus.
- Further characterization of this specific polypeptide could inform targeted vaccine strategies against Visna virus.